-
Uncategorized2 weeks ago
Roche’s late stage pipeline ‘so full,’ CEO Schinecker not feeling pressure to add on
Roche has 19 investigational medicines that could launch by 2030—and even if not all of them make it to market, the company is “well set-up for...
-
Uncategorized2 weeks ago
Samsung Proposes Offer to Acquire Swiss CDMO Specializing in Peptides
Samsung Proposes Offer to Acquire Swiss CDMO Specializing in Peptides
-
Uncategorized2 weeks ago
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
Jideytro is GSK’s first approved product for lung cancer. With its takeover of Nuvalent Bio last month and a deal with Hansoh Pharmaceutical in 2023, the...
-
Uncategorized2 weeks agoExpect a clash at today’s FDA peptide panel
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. We’re almost through the week. But...
-
Uncategorized2 weeks agoSTAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
Eli Lilly reported more results Thursday showing that its next-generation obesity drug is highly efficacious at weight loss, but the data from the study, focused on...
-
Uncategorized2 weeks ago
Nordic biotech’s next act: From fragmentation to global force
Nordic biotech’s next act: From fragmentation to global force
-
Uncategorized2 weeks ago
Scancell to go public after winning reverse merger bid for troubled Neuphoria
Scancell and Neuphoria have made their union official via a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s...
-
Uncategorized2 weeks agoFiling of bipartisan Senate bill boosts momentum for office of men’s health
The Men’s Health Act, a bipartisan bill to establish an office of men’s health within the Department of Health and Human Services, will be introduced in...
-
Uncategorized2 weeks agoOpinion: New billing codes likely to raise maternity care costs
The approach to paying obstetricians and midwives is changing. These changes will likely raise the cost of childbirth, with no guarantee of better maternity outcomes. The...
-
Uncategorized2 weeks ago
Make or break: commercial hires critical for success
With the stakes for successful launches high, and demand for commercial roles increasing, biopharmas must thoughtfully approach not only hiring but also retention. During a BioSpace...
